• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从银屑病患者的需求到治疗结果:“pSORRIDI”经验的结果

From patients' needs to treatment outcomes in psoriasis: Results from the 'pSORRIDI' experience.

作者信息

Esposito Maria, Faleri Sara, Babino Graziella, Messinese Serena, Mazzotta Annamaria, Schipani Caterina, Chimenti Maria Sole, Marchei Massimo, Rizza Stefano, Pandolfi Marta, Chimenti Sergio, Giunta Alessandro

机构信息

Department of Dermatology, University of Rome Tor Vergata, Rome, Italy

Department of Dermatology, University of Rome Tor Vergata, Rome, Italy.

出版信息

J Int Med Res. 2016 Sep;44(1 suppl):95-99. doi: 10.1177/0300060515593265.

DOI:10.1177/0300060515593265
PMID:27683149
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5536524/
Abstract

OBJECTIVE

To evaluate results of the 'pSORRIDI' experience (which is a prevention campaign to evaluate the prevalence of comorbidities, multidisciplinary needs and appropriateness of the therapeutic approach for comorbidities) in patients already being treated for psoriasis.

METHODS

Telephone interviews were conducted in patients with psoriasis, who then underwent comprehensive evaluation and investigation of comorbidities. If necessary, patients were referred to specialist cardiology, endocrinology and/or rheumatology services.

RESULTS

Overall, 72.0% (54/75) of patients required a multidisciplinary consultation. Among patients referred to cardiology, therapeutic adjustment was needed in 33.3% (five of 15) patients and a redefined diagnosis in 26.7% (four of 15) cases. Among patients undergoing endocrinology evaluations, therapeutic adjustment and a redefined diagnosis were needed in 61.1% (11/18) and 33.3% (six of 18) patients, respectively; for rheumatology evaluations, therapeutic adjustment and a redefined diagnosis were needed in 76.2% (16/21) and 19.0% (four of 21) of patients, respectively.

CONCLUSIONS

Among patients with psoriasis, there may be a need for an improvement in the diagnosis of underlying comorbid conditions, and in disease management of both psoriasis and any comorbid conditions.

摘要

目的

评估“pSORRIDI”项目(一项评估合并症患病率、多学科需求及合并症治疗方法适宜性的预防活动)在已接受银屑病治疗的患者中的效果。

方法

对银屑病患者进行电话访谈,随后对其合并症进行全面评估和调查。如有必要,将患者转诊至心脏科、内分泌科和/或风湿科专科服务。

结果

总体而言,72.0%(54/75)的患者需要多学科会诊。在转诊至心脏科的患者中,33.3%(15例中的5例)患者需要调整治疗,26.7%(15例中的4例)病例需要重新明确诊断。在内分泌科评估的患者中,分别有61.1%(18例中的11例)和33.3%(18例中的6例)患者需要调整治疗和重新明确诊断;在风湿科评估的患者中,分别有76.2%(21例中的16例)和19.0%(21例中的4例)患者需要调整治疗和重新明确诊断。

结论

在银屑病患者中,可能需要改善潜在合并症的诊断以及银屑病和任何合并症的疾病管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a53/5536524/7b496d9f6b4b/10.1177_0300060515593265-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a53/5536524/7b496d9f6b4b/10.1177_0300060515593265-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a53/5536524/7b496d9f6b4b/10.1177_0300060515593265-fig1.jpg

相似文献

1
From patients' needs to treatment outcomes in psoriasis: Results from the 'pSORRIDI' experience.从银屑病患者的需求到治疗结果:“pSORRIDI”经验的结果
J Int Med Res. 2016 Sep;44(1 suppl):95-99. doi: 10.1177/0300060515593265.
2
Management of psoriasis and psoriatic arthritis in a combined dermatology and rheumatology clinic.皮肤科和风湿科联合诊所中银屑病和银屑病关节炎的管理。
Arch Dermatol Res. 2012 Jan;304(1):7-13. doi: 10.1007/s00403-011-1172-6.
3
[Treatment of psoriasis with biologics: a survey of dermatological and rheumatological practice at Reims University Hospital].[生物制剂治疗银屑病:兰斯大学医院皮肤科和风湿病科实践调查]
Ann Dermatol Venereol. 2012 May;139(5):355-62. doi: 10.1016/j.annder.2012.03.005. Epub 2012 Apr 21.
4
Multidisciplinary psoriasis and psoriatic arthritis unit: report of 4 years' experience.多学科银屑病和银屑病关节炎诊疗单元:4年经验报告
Actas Dermosifiliogr. 2014 May;105(4):371-7. doi: 10.1016/j.ad.2013.10.009. Epub 2013 Dec 18.
5
Association of psoriasis and/or psoriatic arthritis with autoimmune diseases: the experience of two Italian integrated Dermatology/Rheumatology outpatient clinics.银屑病和/或银屑病关节炎与自身免疫性疾病的关联:两家意大利综合皮肤科/风湿病门诊的经验。
J Eur Acad Dermatol Venereol. 2015 Nov;29(11):2160-8. doi: 10.1111/jdv.13170. Epub 2015 Apr 16.
6
Tuscan consensus on the diagnosis, treatment and follow-up of moderate-to-severe psoriasis.托斯卡纳关于中重度银屑病诊断、治疗及随访的共识
G Ital Dermatol Venereol. 2017 Apr;152(2):99-108. doi: 10.23736/S0392-0488.16.05005-7. Epub 2015 Jan 14.
7
A review of health outcomes in patients with psoriasis.银屑病患者健康结局的综述。
Dermatol Clin. 2012 Jan;30(1):61-72, viii. doi: 10.1016/j.det.2011.08.012. Epub 2011 Oct 19.
8
A report of 4 years of experience of a multidisciplinary unit of psoriasis and psoriatic arthritis.一份关于银屑病和银屑病关节炎多学科诊疗单元4年经验的报告。
Reumatol Clin. 2014 May-Jun;10(3):141-6. doi: 10.1016/j.reuma.2014.01.004. Epub 2014 Mar 20.
9
Identifying Performance Gaps in Comorbidity and Risk Factor Screening, Prevention, and Counseling Behaviors of Providers Caring for Children with Psoriasis.识别照顾银屑病患儿的医护人员在合并症及风险因素筛查、预防和咨询行为方面的表现差距。
Pediatr Dermatol. 2015 Nov-Dec;32(6):813-8. doi: 10.1111/pde.12669. Epub 2015 Sep 4.
10
Rheumatologists' recommendations on what to do in the dermatology office to evaluate and manage psoriasis patients' joint symptoms.风湿病医生关于在皮肤科诊室评估和管理银屑病患者关节症状时应做什么的建议。
J Dermatolog Treat. 2009;20(6):350-3. doi: 10.3109/09546630902817887.

引用本文的文献

1
Epidemiology of psoriasis in Italy: burden, cost, comorbidities and patients' satisfaction. A systematic review.意大利银屑病的流行病学:负担、成本、合并症和患者满意度。系统评价。
Acta Biomed. 2022 Dec 16;93(6):e2022332. doi: 10.23750/abm.v93i6.13177.
2
Multidisciplinary working in the management of axial and peripheral spondyloarthritis.中轴型和外周型脊柱关节炎管理中的多学科协作
Ther Adv Musculoskelet Dis. 2020 Dec 10;12:1759720X20975888. doi: 10.1177/1759720X20975888. eCollection 2020.
3
PsA-Disk, a novel visual instrument to evaluate psoriatic arthritis in psoriatic patients: an Italian derma-rheuma multicentre study.

本文引用的文献

1
Understanding therapeutic pathways and comorbidities in psoriasis.了解银屑病的治疗途径和合并症。
Semin Cutan Med Surg. 2014 Mar;33(2 Suppl 2):S20-3. doi: 10.12788/j.sder.0067.
2
Survival rate of antitumour necrosis factor-α treatments for psoriasis in routine dermatological practice: a multicentre observational study.在常规皮肤科实践中抗肿瘤坏死因子-α治疗银屑病的存活率:一项多中心观察性研究。
Br J Dermatol. 2013 Sep;169(3):666-72. doi: 10.1111/bjd.12422.
3
Global epidemiology of psoriasis: a systematic review of incidence and prevalence.
PsA-Disk,一种用于评估银屑病患者银屑病关节炎的新型视觉仪器:一项意大利皮肤-风湿病多中心研究。
Ther Adv Chronic Dis. 2019 May 14;10:2040622319847056. doi: 10.1177/2040622319847056. eCollection 2019.
4
New insight into the pathogenesis of nail psoriasis and overview of treatment strategies.甲银屑病发病机制的新见解及治疗策略概述
Drug Des Devel Ther. 2017 Aug 30;11:2527-2535. doi: 10.2147/DDDT.S136986. eCollection 2017.
5
Spotlight on ixekizumab for the treatment of moderate-to-severe plaque psoriasis: design, development, and use in therapy.司库奇尤单抗治疗中重度斑块状银屑病的聚焦:设计、研发及治疗应用
Drug Des Devel Ther. 2017 Jun 2;11:1643-1651. doi: 10.2147/DDDT.S92128. eCollection 2017.
全球银屑病流行病学:发病率和患病率的系统评价。
J Invest Dermatol. 2013 Feb;133(2):377-85. doi: 10.1038/jid.2012.339. Epub 2012 Sep 27.
4
Adherence in the treatment of psoriasis: a systematic review.银屑病治疗中的依从性:系统评价。
Dermatology. 2011;222(4):363-74. doi: 10.1159/000329026. Epub 2011 Jul 13.
5
Metabolic comorbidities and psoriasis.代谢合并症与银屑病。
Acta Dermatovenerol Croat. 2010;18(4):297-304.
6
Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions.银屑病与系统性炎症性疾病:皮肤疾病与合并症之间潜在的机制联系。
J Invest Dermatol. 2010 Jul;130(7):1785-96. doi: 10.1038/jid.2010.103. Epub 2010 May 6.
7
Comorbidities in patients with psoriasis.银屑病患者的合并症。
Am J Med. 2009 Dec;122(12):1150.e1-9. doi: 10.1016/j.amjmed.2009.06.021.
8
Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use.皮肤病生活质量指数(DLQI)——一种用于日常临床的简单实用测量方法。
Clin Exp Dermatol. 1994 May;19(3):210-6. doi: 10.1111/j.1365-2230.1994.tb01167.x.
9
Severe psoriasis--oral therapy with a new retinoid.重度银屑病——一种新型维甲酸的口服治疗
Dermatologica. 1978;157(4):238-44. doi: 10.1159/000250839.